Nila Kartika Wati

Breaking Down Barriers: METAvivor Joins Bipartisan Coalition to Support the Clinical Trial Modernization Act

• Patient Advocacy and Support

Breaking Down Barriers: METAvivor Joins Bipartisan Coalition to Support the Clinical Trial Modernization Act

Nila Kartika Wati July 24, 2026

In a significant move for the metastatic breast cancer (MBC) community, METAvivor—a leading non-profit organization dedicated to...

Read More Read more about Breaking Down Barriers: METAvivor Joins Bipartisan Coalition to Support the Clinical Trial Modernization Act

The Crisis of Credibility: Navigating the Shifting Landscape of Public Health Trust

• Breast Cancer Legislation and Policy

The Crisis of Credibility: Navigating the Shifting Landscape of Public Health Trust

Nila Kartika Wati July 23, 2026

In an era defined by rapid technological advancement and profound social fragmentation, the public’s relationship with health...

Read More Read more about The Crisis of Credibility: Navigating the Shifting Landscape of Public Health Trust

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

• Medical Research and Clinical Trials

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

Nila Kartika Wati July 23, 2026

London, UK – In a significant stride towards revolutionizing cancer treatment, scientists at King’s College London have...

Read More Read more about Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

FDA Approves Gedatolisib (Revtorpyk) for HR-Positive/HER2-Negative Metastatic Breast Cancer: A New Era in PAM Pathway Inhibition

• Patient Advocacy and Support

FDA Approves Gedatolisib (Revtorpyk) for HR-Positive/HER2-Negative Metastatic Breast Cancer: A New Era in PAM Pathway Inhibition

Nila Kartika Wati July 23, 2026

The landscape of metastatic breast cancer treatment has undergone a significant transformation with the U.S. Food and...

Read More Read more about FDA Approves Gedatolisib (Revtorpyk) for HR-Positive/HER2-Negative Metastatic Breast Cancer: A New Era in PAM Pathway Inhibition

Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

• Treatment Innovations

Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

Nila Kartika Wati July 22, 2026

In a significant advancement for genetic medicine, Arrowhead Pharmaceuticals has announced resounding success in two late-stage clinical...

Read More Read more about Arrowhead Pharmaceuticals’ Plozasiran Scores Major Win in Phase 3 Trials, Signaling Potential Market Shift

Four Years of 988: Assessing the Impact and Future of America’s Crisis Lifeline

• Breast Cancer Legislation and Policy

Four Years of 988: Assessing the Impact and Future of America’s Crisis Lifeline

Nila Kartika Wati July 22, 2026

Since its inception on July 16, 2022, the 988 Suicide & Crisis Lifeline has evolved from a...

Read More Read more about Four Years of 988: Assessing the Impact and Future of America’s Crisis Lifeline

Navigating the Invisible Weight: Addressing the Mental Health Crisis Among Previvors

• Survivorship and Post-Treatment

Navigating the Invisible Weight: Addressing the Mental Health Crisis Among Previvors

Nila Kartika Wati July 22, 2026

By Editorial Staff June 30, 2026 The term "previvor"—a portmanteau of "preventive" and "survivor"—has entered the modern...

Read More Read more about Navigating the Invisible Weight: Addressing the Mental Health Crisis Among Previvors

Global Health Visionaries Honoured: Celebrating Excellence at the 79th World Health Assembly

• Global Breast Cancer Awareness

Global Health Visionaries Honoured: Celebrating Excellence at the 79th World Health Assembly

Nila Kartika Wati July 21, 2026

GENEVA – The global health community gathered in Geneva this week as the 79th World Health Assembly...

Read More Read more about Global Health Visionaries Honoured: Celebrating Excellence at the 79th World Health Assembly

Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

• Medical Research and Clinical Trials

Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Nila Kartika Wati July 20, 2026

London, UK – In a significant stride towards understanding the complex interplay between ageing and cancer, an...

Read More Read more about Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Beyond the Pink Ribbon: Men’s Breast Cancer – A Story of Vigilance and Hope

• Patient Advocacy and Support

Beyond the Pink Ribbon: Men’s Breast Cancer – A Story of Vigilance and Hope

Nila Kartika Wati July 18, 2026

Introduction: Unveiling a Less-Discussed Reality Breast cancer, a disease overwhelmingly associated with women, casts a long shadow...

Read More Read more about Beyond the Pink Ribbon: Men’s Breast Cancer – A Story of Vigilance and Hope